The suppression of involuntary movements with tetrabenazine.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001259:Ataxia / Q000188:drug therapy; D001264:Athetosis / Q000188:drug therapy; D003863:Depression / Q000139:chemically induced; D004027:Diencephalon; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy*; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy; D013747:Tetrabenazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014202:Tremor / Q000188:drug therapy
D013747:Tetrabenazine